LU86163A1 - Flavolignanderivate,verfahren zu deren herstellung und arzneimittel,die diese verbindungen enthalten - Google Patents

Flavolignanderivate,verfahren zu deren herstellung und arzneimittel,die diese verbindungen enthalten Download PDF

Info

Publication number
LU86163A1
LU86163A1 LU86163A LU86163A LU86163A1 LU 86163 A1 LU86163 A1 LU 86163A1 LU 86163 A LU86163 A LU 86163A LU 86163 A LU86163 A LU 86163A LU 86163 A1 LU86163 A1 LU 86163A1
Authority
LU
Luxembourg
Prior art keywords
alk
ethyl acetate
independently represent
silibinin
animals
Prior art date
Application number
LU86163A
Other languages
German (de)
English (en)
Inventor
Reinhard Braatz
Klaus Goerler
Guenter Halbach
Hartwig Soicke
Karlheinz Schmidt
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of LU86163A1 publication Critical patent/LU86163A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
LU86163A 1984-11-22 1985-11-13 Flavolignanderivate,verfahren zu deren herstellung und arzneimittel,die diese verbindungen enthalten LU86163A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3442639 1984-11-22
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (1)

Publication Number Publication Date
LU86163A1 true LU86163A1 (de) 1986-03-24

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86163A LU86163A1 (de) 1984-11-22 1985-11-13 Flavolignanderivate,verfahren zu deren herstellung und arzneimittel,die diese verbindungen enthalten

Country Status (29)

Country Link
JP (1) JPS61143377A (hu)
KR (1) KR870001020B1 (hu)
AR (1) AR240931A1 (hu)
AT (1) AT393268B (hu)
BE (1) BE903693A (hu)
CA (1) CA1337124C (hu)
CH (1) CH659473A5 (hu)
CS (1) CS273610B2 (hu)
DD (1) DD259191A1 (hu)
DE (1) DE3442639A1 (hu)
DK (1) DK164865C (hu)
EG (1) EG19424A (hu)
ES (1) ES8609311A1 (hu)
FI (1) FI84064C (hu)
FR (1) FR2573427B1 (hu)
GB (1) GB2167414B (hu)
HU (1) HU195503B (hu)
IE (1) IE58791B1 (hu)
IT (1) IT1190426B (hu)
LU (1) LU86163A1 (hu)
MX (1) MX168415B (hu)
NL (1) NL192387C (hu)
NO (1) NO160205C (hu)
PL (1) PL146890B1 (hu)
PT (1) PT81532B (hu)
SE (1) SE465676B (hu)
SU (1) SU1436875A3 (hu)
YU (1) YU43689B (hu)
ZA (1) ZA858951B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
BRPI0608402B8 (pt) * 2005-03-11 2021-05-25 Armaron Bio Pty Ltd compostos de flavonóide e composições compreendendo os mesmos
CN102300570B (zh) * 2007-11-15 2015-01-14 马道斯有限责任公司 用于治疗肝炎的水飞蓟宾组分
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
CA2761656C (en) * 2009-05-14 2017-02-07 Lucio Claudio Rovati Amorphous silibinin for the treatment of viral hepatitis
AU2013286721B2 (en) 2012-07-05 2018-04-26 Nutramax Laboratories, Inc. Compositions comprising a sulforaphane or a sulforaphane precursor and milk thistle extract or powder
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
FI854535A (fi) 1986-05-23
PT81532A (de) 1985-12-01
CS273610B2 (en) 1991-03-12
IE58791B1 (en) 1993-11-17
GB2167414B (en) 1989-01-11
GB2167414A (en) 1986-05-29
PL256374A1 (en) 1986-12-02
BE903693A (fr) 1986-05-22
FR2573427A1 (fr) 1986-05-23
AR240931A1 (es) 1991-03-27
DK164865C (da) 1993-01-18
CS837885A2 (en) 1990-08-14
DD259191A1 (de) 1988-08-17
NO160205B (no) 1988-12-12
FI854535A0 (fi) 1985-11-18
NL192387B (nl) 1997-03-03
DK537785A (da) 1986-05-23
FI84064B (fi) 1991-06-28
IE852808L (en) 1986-05-22
HUT40114A (en) 1986-11-28
SU1436875A3 (ru) 1988-11-07
ES549116A0 (es) 1986-09-01
YU178685A (en) 1988-02-29
IT8522932A0 (it) 1985-11-21
CH659473A5 (de) 1987-01-30
IT1190426B (it) 1988-02-16
DE3442639C2 (hu) 1989-08-10
FI84064C (fi) 1991-10-10
FR2573427B1 (fr) 1989-03-10
ZA858951B (en) 1986-08-27
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
DK164865B (da) 1992-08-31
DE3442639A1 (de) 1986-05-22
GB8528226D0 (en) 1985-12-18
ATA337185A (de) 1991-02-15
EG19424A (en) 1995-02-28
NL192387C (nl) 1997-07-04
SE8505487L (sv) 1986-05-23
YU43689B (en) 1989-10-31
AT393268B (de) 1991-09-25
PT81532B (pt) 1987-11-11
ES8609311A1 (es) 1986-09-01
DK537785D0 (da) 1985-11-21
SE8505487D0 (sv) 1985-11-20
HU195503B (en) 1988-05-30
NO854655L (no) 1986-05-23
MX168415B (es) 1993-05-24
NL8503171A (nl) 1986-06-16
JPS61143377A (ja) 1986-07-01
NO160205C (no) 1989-03-22
AR240931A2 (es) 1991-03-27
KR870001020B1 (ko) 1987-05-23
JPH0432073B2 (hu) 1992-05-28
KR860004056A (ko) 1986-06-16
CA1337124C (en) 1995-09-26

Similar Documents

Publication Publication Date Title
DE2549783C3 (de) Triglyceride mit entzündungshemmender Wirkung
DE2711927A1 (de) Pharmazeutisch wirksame polyphenole und verfahren zu ihrer herstellung
EP0149242A2 (de) 1-(2-Hydroxyaryl)-alkan-1-on-oxime, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0472501B1 (de) Codeinsalz einer substituierten Carbonsäure, Verfahren zu seiner Herstellung, seine Verwendung und pharmazeutische Präparate
AT391315B (de) Verfahren zur herstellung von isosilybinfreiem silibinin
LU86163A1 (de) Flavolignanderivate,verfahren zu deren herstellung und arzneimittel,die diese verbindungen enthalten
EP0520414B1 (de) Verfahren zur Gewinnung von Diacetylrhein
EP0127726A1 (de) Hydroxamsäuren, ihre Herstellung und ihre Verwendung in pharmazeutischen Mitteln
DE102004032440A1 (de) Verwendung von trisubstituierten Benzopyranonen
DE69927813T2 (de) Hyperforin-derivate, ihre verwendung sowie diese enthaltende zubereitungen
DE2434929C2 (de) p-Acetylaminophenolester von Phenylsalicylsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0501206B1 (de) Phenonverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
CH633715A5 (de) Verfahren zur erzeugung einer antilithiatisch wirkenden substanz und ein antilithiaticum.
EP0664131A1 (de) Optimal freisetzende Kava-Extrakte
EP0310757B1 (de) Verfahren zur Herstellung eines Propolis-Äthanolextraktes
DE2847836C3 (de) Verfahren zur Gewinnung eines Terpengemisches mit antipsoriatischer Wirksamkeit
EP0544880B1 (de) Verfahren zur herstellung von diacetylrhein
DE60023585T2 (de) Zubereitung eines Arzneimittels enthaltend Catechich- oder Flavonylisch-ähnliche Polyphenolverbindungen aus Pflanzen, insbesondere für die Behandlung von Gingivitis
DE2243777A1 (de) Dihydrochinolinderivate, ihre verwendung und verfahren zur herstellung derselben
DE2503135C3 (de) Terpenverbindungen, Verfahren zu ihrer Herstellung und diese Produkte enthaltende Arzneimittel
DE2415982A1 (de) Ester von 2- eckige klammer auf (chinolyl-4')-amino eckige klammer zu -benzoesaeuren
DE2609533A1 (de) Verfahren zur extraktion von wirkstoffen, insbesondere von heterosidestern, der kaffeesaeure, sowie diese verbindungen enthaltende arzneimittel
DE2729903A1 (de) Antithrombosemittel
DE60124315T2 (de) Eine aus der pflanze humboldtia decurrens gewonnene antidiabetische verbindung und ein verfahren zu ihrer herstellung
DE2707675A1 (de) Arzneimittel zur aufloesung bzw. teilweisen aufloesung von gallensteinen